Myovant Sciences Ltd/ BMG637AM1024 /
2023-03-09 10:10:00 PM | Chg. - | Volume | Bid10:59:55 PM | Ask12:00:00 AM | High | Low |
---|---|---|---|---|---|---|
26.98USD | - | 2.26 mill. Turnover: 58.06 mill. |
26.96Bid Size: 2,200 | 27.01Ask Size: 500 | 27.00 | 26.98 |
GlobeNewswire
2023-11-05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences...
GlobeNewswire
2023-10-27
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences...
GlobeNewswire
2023-10-19
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences...
GlobeNewswire
2023-10-11
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences...
GlobeNewswire
2023-10-03
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences...
GlobeNewswire
2023-09-26
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences...
GlobeNewswire
2022-02-25
Myovant Sciences Receives Positive CHMP Opinion for ORGOVYX® (relugolix) for the Treatment of Advanc...
GlobeNewswire
2022-02-01
The Fibroid Foundation Announces Fibroid Summit 2022 - a Patient-Hosted Research Conference
GlobeNewswire
2022-01-26
Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and Corporate Upd...
GlobeNewswire
2022-01-10
Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Year 2021
GlobeNewswire
2022-01-03
Myovant Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire
2021-11-23
Myovant Sciences to Participate in the Evercore ISI 4th Annual HealthCONx Conference
GlobeNewswire
2021-10-26
Myovant Sciences Announces Financial Results for Second Quarter of Fiscal Year 2021 and Corporate Up...
GlobeNewswire
2021-10-19
Myovant Sciences and Pfizer Present Data on Relugolix Combination Therapy from Studies in Uterine Fi...
GlobeNewswire
2021-10-12
Myovant Sciences to Host Second Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Ti...
GlobeNewswire
2021-09-09
Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBR...
GlobeNewswire
2021-09-01
Myovant Sciences to Participate in the 2021 Baird Global Healthcare Conference
GlobeNewswire
2021-08-13
Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of ...
GlobeNewswire
2021-08-12
Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights
GlobeNewswire
2021-08-12
Myovant Sciences Appoints Uneek Mehra as Chief Financial and Business Officer